Cargando…
Pompe disease: from pathophysiology to therapy and back again
Pompe disease is a lysosomal storage disorder in which acid alpha-glucosidase (GAA) is deficient or absent. Deficiency of this lysosomal enzyme results in progressive expansion of glycogen-filled lysosomes in multiple tissues, with cardiac and skeletal muscle being the most severely affected. The cl...
Autores principales: | Lim, Jeong-A, Li, Lishu, Raben, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135233/ https://www.ncbi.nlm.nih.gov/pubmed/25183957 http://dx.doi.org/10.3389/fnagi.2014.00177 |
Ejemplares similares
-
Pompe disease: Shared and unshared features of lysosomal storage disorders
por: Lim, Jeong-A, et al.
Publicado: (2015) -
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease
por: Lim, Jeong‐A, et al.
Publicado: (2017) -
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013) -
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease
por: Meena, Naresh Kumar, et al.
Publicado: (2020) -
Atg5(flox)-Derived Autophagy-Deficient Model of Pompe Disease: Does It Tell the Whole Story?
por: Lim, Jeong-A, et al.
Publicado: (2017)